x

Pesquisar um projeto de investigação

* (*) campo(s) de preenchimento obrigatório

47 Resultado(s)

Ordenados por

Financiado por um membro do IRDiRC =

Projetos de investigação

ALEMANHA

Berlin
BERLIN

Molecular causes ans target molecules in tumor progression of malignant brain tumors
Charité - Universitätsmedizin Berlin (CCM)
Institut für Neuropathologie

AUSTRIA

WIEN
WIEN

Disease progression and treatment-induced alterations in glioblastoma
Allgemeines Krankenhaus der Stadt Wien
Klinisches Institut für Neurologie

AUSTRIA

WIEN
WIEN

Fibroblast Growth Factor Receptor 4 in Glioblastoma
Medizinische Universität Wien
Institut für Krebsforschung

ESPANHA

Andalucía
GRANADA

ESPANHA

Cataluña
BARCELONA

Financiado por um membro do IRDiRCIntratumoral heterogeneity in glioblastoma. Therapeutic implications
Vall d'Hebron Instituto de Oncología - Centro Cellex
Grupo de expresión génica y cáncer

ESPANHA

Cataluña
LLEIDA

Financiado por um membro do IRDiRCRegulation of the autophagic flux in Glioblastoma: towards the identification of novel therapeutical strategies
Instituto de Investigación Biomédica de Lleida (IRBLLEIDA)
Señalización por calcio y diferenciación neuronal

ESPANHA

Comunidad Valenciana
VALENCIA

FRANCA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Development of a new drug therapy for glioblastoma
Parc scientifique et technologiques de Luminy
PHARMAXON

ITALIA

LAZIO
ROMA

Financiado por um membro do IRDiRCTHERAGLIO: Microbubble driven multimodal imaging and theranostics for gliomas - IT
Università degli Studi di Roma Tor Vergata
Dipartimento di Scienze e Tecnologie Chimiche

PORTUGAL

CENTRO
BRAGA

REINO UNIDO

Greater London
LONDON

Financiado por um membro do IRDiRCDARTRIX: DARPin Targeted Magnetic Hyperthermic Therapy for Glioblastoma - UK
UCL Cancer Institute, University College London
Recombinant Antibody Therapeutics Group

SUECIA

Landstinget i Uppsala län
UPPSALA

ALEMANHA

Baden-Württemberg
HEIDELBERG

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

AUSTRIA

WIEN
WIEN

7 Tesla MR spectoscopy in diffusely infiltrating gliomas
Medizinische Universität Wien
Exzellenzzentrum für Hochfeld-MR

ESPANHA

Navarra
PAMPLONA

Financiado por um membro do IRDiRCNew therapeutic strategies for diffuse intrinsic pontine gliomas and pediatric high grade gliomas
CIMA - Centro de Investigación Médica Aplicada
Programa de Tumores sólidos y biomarcadores

CANADA

Québec
MONTRÉAL

Financiado por um membro do IRDiRCIdentification and characterization of genes involved in the genesis and progression of pediatric astrocytomas
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Financiado por um membro do IRDiRCRole of chromatin remodeling in the genesis of pediatric and young adult astrocytomes
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Financiado por um membro do IRDiRCThe ICHANGE (International CHildhood Astrocytomas iNtegrated Genomics and Epigenomics) Consortium
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

ALEMANHA

Nordrhein-Westfalen
MÜNSTER

Cellular and molecular mechanisms of glioma invasion
Institut für Neuropathologie der Medizinischen Fakultät Münster
Institut für Neuropathologie

PORTUGAL

SUL
LISBOA

Papel da proteína cinase WNK2 como gene supressor de gliomas malignos
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Unidade de Investigação e Desenvolvimento

REINO UNIDO

Nottinghamshire
NOTTINGHAM

REINO UNIDO

West Midlands
BIRMINGHAM

SUECIA

Landstinget i Uppsala län
UPPSALA

Molecular mechanisms of the origine of glioma development
Uppsala Universitet
Department of Immunology, Genetics and Pathology

ITALIA

CAMPANIA
NAPOLI

Cytogenetic characterization of central nervous system tumors
P.S.I. "Elena d'Aosta"
U.O.C. Servizio di Genetica

FRANCA

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

ITALIA

LOMBARDIA
MILANO

RARECARE: surveillance of rare cancers in Europe (coordination)
Fondazione IRCCS Istituto Nazionale dei Tumori
S.S. di Epidemiologia Valutativa

REINO UNIDO

Tyne & Wear
NEWCASTLE UPON TYNE

EPOC: European paediatric oncology off-patent medicines consortium (coordination)
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

Projetos de investigação multicêntricos